Factors associated with adherence to Antiretroviral Therapy (ART) among adult people living with HIV and attending their clinical care, Eastern Ethiopia by Shiferaw Letta et al.
RESEARCH ARTICLE Open Access
Factors associated with adherence to
Antiretroviral Therapy (ART) among adult
people living with HIV and attending their
clinical care, Eastern Ethiopia
Shiferaw Letta1*, Asrat Demissie2, Lemessa Oljira3 and Yadeta Dessie3
Abstract
Background: To attain a successful treatment outcome, Antiretroviral Therapy (ART) treatment for people living
with HIV requires more than 95 % adherence level. The adherence level varies depending on different population
contexts. Thus, the objective of this study was to investigate ART adherence level among HIV positive patients
attending their clinical care in public health facilities in Harar and Dire Dawa, Eastern Ethiopia.
Methods: We conducted a cross-sectional study among 626 ART attendees. Data were collected using a structured
questionnaire with a face-to-face interview. ART adherence was considered when taking all antiretroviral treatment
in a correctly prescribed doses at a right time (no dose missed or delayed for greater than or equal to 90 min) in
the week prior to the study. Multivariable logistic analysis was applied to examine the association between the
dependent and independent variables. Statistical significance was set at p-value <0.05.
Results: The level of ART adherence was 85 %. Adherence was more likely among patients of 35–44 years
(AOR = 2.39; 95 % CI = 1.15–5.01), had monthly income of 501.00–999.00 Ethiopian Birr (ETB) (AOR = 6.73; 95 %
CI = 2.71–16.75), no history of opportunistic infection (AOR = 2.81; 95 % CI = 1.47–5.36), and had good family
support (AOR = 2.61; 95 % CI = 1.45–4.72). However, those who did not disclose their sero-status (AOR = 0.45;
95 % CI = 0.21–0.97) and did experience depression (AOR = 0.36; 95 % CI = 0.21–0.61) were less likely adherent
than their counter parts.
Conclusions: The level of ART adherence was sub-optimal. Concerted and collaborative efforts through
effective and efficient interventions are needed in view of the identified factors in order to improve the
adherence level.
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Background
The increased availability of ART has essentially im-
proved the survival rates through lowering incidence of
opportunistic infections among people living with HIV.
Even though access to ART is vital; ensuring the pa-
tients’ adherence to the prescribed regimen is equally
important. In order to attain a successful treatment
outcome, the current treatment for HIV/AIDS regimen
requires adherence level of greater than 95 % [1–5].
Improving adherence requires collaboration with the
patient in an effort to understand and improve individ-
ual impediments to adherence. This can generally be
done by establishing dedicated time to educate every
patient, plan for adherence, and maintain support and
collaboration throughout the course of treatments. In
this way, adherence can regularly be assessed, problems
can be averted, and side effects can be dealt [6]. There
are many alterable factors known to affect the treatment
adherence. These are depression, regimen complexity,
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medication side effects, and relationship between pa-
tients and care providers which should be addressed
prior to starting their treatments and throughout the on-
going treatments [7–9].
In Ethiopia, a numbers of studies have been conducted
on ART adherence and factors associated with ART
adherence [7–10]. The studies have reported a range of
factors influencing ART adherence at various levels;
however, the findings were varying depending on the
contexts of the studies. In this regard, there have been
very limited researches in Eastern Ethiopia. Therefore,
with this study, we intended to determine the adherence
level and its associated factors among adult people living
with HIV and attending their clinical care in public
health facilities found in Harar and Dire Dawa towns,
Eastern Ethiopia.
Methods and procedures
Study setting and participants
The study was conducted in Harar and Dire Dawa towns
which are located in the East of Addis Ababa—the cap-
ital city of Ethiopia. There were seven health centers and
one public health hospital in Dire Dawa town, and three
health centers, two military and two public hospitals in
the Harar town which were providing ART service and
care for patients [11].
People living with HIV/AIDS, who are 18 years old
and above, able to hear and communicate well or men-
tally fit and being on ART at least for 3 months were
included in the study. The sample size of the study was
calculated using a single population proportion formula
with the assumptions of 95 % Confidence Level (CL),
marginal error (d) of 0.05, and adherence level (P) of
0.74 % which was taken from previous study in Ethiopia
[10]. Through applying a finite population correction,
the initial calculated sample size was 296. After adding
10 % non-response rate and considering a design effect
of two, the final sample size calculated was 626. A multi
stage sampling technique was applied to select study
participants. First, from seven health centers and one
public health hospital in Dire Dawa, three health centers
and one hospital were randomly selected. In the same
manner, in Harar, one from the two hospitals and two
from the three health centers were selected. The calcu-
lated sample size was allocated in proportional to the
number of patients in each health facility. Finally, the
respondents were selected through simple random sam-
pling technique by using a sampling frame that was
developed from the registration book of the patients.
Data collection
Face-to-face interview was applied to collect the data.
Seven trained Diploma and Bachelor of Science (BSc)
holder nurses who can speak the local languages fluently:
Afan Oromo, Amharic and Semoligna collected the data.
The interviews were undertaken in private room after
signed written consent from the study subjects. Pretest
was done on 5 % of the total sample size at Chiro Hospital
which is one of the government hospital not included in
the study. Interviewers and supervisors were trained for
3 days prior to the implementation of the actual field work
on the objective, data collection techniques, maintaining
data quality, and techniques of interview of the study. The
data consistency and completeness were checked on daily
basis by supervisors and the principal investigator.
Measurements
ART adherence was defined as taking all pills in correctly
prescribed doses at right time (no dose missed or delayed
for greater than or equal to 90 min) [7]. According to this
study, the adherence was measured by self- reported 7 day
recall dose adherence. A structured pre tested question-
naire which was developed from different literatures was
used for the purpose of data collection. The dependent
variable of the study was adherence to ART and the inde-
pendent variables were socio-demographic and economic
factors, psychosocial and medication related characteris-
tics. Depression was measured using a scale of 20-items
from Center for Epidemiological Studies Depression
which helps to examine different manifestations; for in-
stance, restlessness, sleeplessness, poor appetite, loss of
interest and feeling of loneliness in the week right before
the study [12]. The internal consistency (Cronbach Alpha)
of the scale was greater than 0.80. The responses were
summed and those scored above the mean were catego-
rized as depressed.
Data analysis
The data was cleaned, coded and entered in to Epidata
software (Version 3.1) and exported to SPSS version
16.0 for analysis. First the descriptive analysis was con-
ducted and the result was displayed in the form of ta-
bles, charts and figures. Then binary logistic analysis
was conducted to measure the association between the
dependent variable and independent variables: patient
factors (socio-demographic, economic, socio cultural
and psychosocial factors), medication and related
characteristics (pill burden, treatment complexity,
missed dose and medication side effects), system fac-
tors include access and health care providers’ related
characteristics and social support, stigma, and disclos-
ure status were among community related factors
using odds ratio and 95 % confidence interval. Finally,
multivariable logistic regression analysis was con-
ducted in order to identify the factors associated with
the adherence level. Statistical significance was set at
P-value <0.05.
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Ethical considerations
Ethical approval for the study was secured from Institu-
tional Research Ethics Review Committee of Haramaya
University College of Health and Medical Sciences. Im-
portant information about the purpose of the study and
its procedures were explained for the respondents with
the assurance of maintaining their confidentiality in a
strict manner. Participation in the study was based on
each patient’s will and ability to give informed consent.
Detail explanations had been given and they were as-
sured that disagreements and discontinuations from the
study did not have a negative effect on services to be
provided at any time. The interviews were made after
getting written informed consents from each patient.
Results
Brief participants’ characteristics
A total of 620 adult HIV patients on ART participated in
the study. The mean age (±SD) of study participants was
36.7 (±10.7) where 42.3 % were in age group of 25–34
years; male constituted 313 (50.5 %); most of the study
participants 254 (41 %) were married; and 287 (46.0 %) of
them had attended elementary school. About one-third,
161 (26 %) were daily laborers; 133 (22 %) earned <500.00
Ethiopian Birr (ETB) (20.00 ETB = 1USD) per month; and
322 (56.8 %) had 2–4 family members (Table 1).
Medication and related characteristics
The majority of the respondents, 420 (67.7 %), were tested
for HIV before 24 weeks (2-years) and among those pa-
tients who were on ART, 369 (59.5 %) had started ART
before 24 weeks (2 years). Based on patients’ record re-
view, the respondents were on combination of ART drugs
with regimen of Zidovudine (AZT), Lamivudine (3TC),
Nevirapine (NVP), Efavirenz (EFV), Stavudine (d4t) and
Tenofovir (TDF). About one-third of the participants 189
(30.1 %) were on AZT-3TC-NVP. High proportion of pa-
tients 293 (47.3 %) were taking 3 tablets per day while few
of the respondents 13 (2.1 %) were taking more than or
equal to 5 tablets per day including non-ART drugs
(Table 2).
ART adherence level and reasons for missing their
treatment
The level of dose adherence was 85 %; whereas, the rest
15 % missed doses (one and more) of their drugs in the
last seven days (non-adherent). The main reasons given
for missing their treatment were forgetting 37(39.8 %),
being away from home 20 (21.5 %), and followed by be-
ing busy with different activities (Fig. 1).
Factors associated adherence to ART
Patients who were in the age of 35–44 years old were
2.4 times (AOR = 2.39; 95 % CI = 1.15–5.01) more
adherent than those older age group (≥45 years).
Patients who earned an average income of 501–999 ETB
per month were 6.73 times (AOR = 6.73; 95 % CI = 2.71–
16.75) more likely adhered than those earned less than
500.00 ETB. Patients who took two tablets (AOR =
12.98; 95 % CI = 2.78–60.59), three tablets (AOR = 12.90;
95 % CI = 2.87–57.94) and four tablets (AOR = 5.87;
95 % CI = 1.02–28.54) per day were more adherent than
Table 1 Socio-demographic and economic characteristics
among adult patients on ART in public health institutions in
Harar and Dire Dawa towns, Eastern Ethiopia, 2012

























Government employee 59 9.5
Private employee 112 18.1
Daily laborer 117 18.9
Merchant 50 8.1
Have no job 182 29.4
Others 134 16.0
Average monthly income
<500.00 ETB 130 21.0
501.00–999.00ETB 66 10.6
>1000.00 ETB 75 12.1
Difficult to determine 349 56.3
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those taking five and more tablets. Those who did not
have history of opportunistic infection were 2.8 times
(AOR = 2.81; 95 % CI = 1.47–5.36) more likely adhered
than those experienced opportunistic infection. The
odds of adhering to ART was 2.6 times higher among
those getting good family support (AOR = 2.61; 95 %
CI = 1.45–4.72) than those who had poor family sup-
port. On the other hand, adherence was less by 55 %
(AOR = 0.45; 95 % CI = 0.21–0.97) among patients who
did not disclose their sero-status to any family member
than their counter parts and by 64 % (AOR = 0.36; 95 %
CI = 0.21–0.61) among patients who did experience de-
pression compared to those who did not (Table 3).
Discussion
The level of adherence identified was 85 %. The reasons
for skipping doses were forgetting to take, being far from
home, being busy and running out of pill. Factors associ-
ated with the ART adherence were age, income, pill bur-
den, opportunistic infections, disclosure and depression
status and family support.
The level of adherence identified here was 85 % which
is lower than the recommended level of adherence. In
the current recommendation, at least 95 % of ART ad-
herence level is required to suppress viral replication,
show clinical improvement and increased CD4 count
[13]. This implicates maximum effort still are needed to
push up the adherence to the status of the recom-
mended level. Despite the adherence level is less than
the recommended level; the obtained result was higher
than other studies in different parts of Ethiopia such as
Addis Ababa [10], Yirgalam [7], and Jimma [8, 9]. One
possible explanation might be many of the participants
in this study have been on ART for longer duration, and
those taking the drug/s for a longer duration usually
acquire skills how to deal with some of the obstacles
hindering them not to adhere. Further, context varia-
tions may also explain the difference observed.
The main reasons for skipping were forgetting to
take, being far from home, being busy, running out of
pill, drug toxicity, too ill and fear of stigma which
were similar to other studies in Jimma [8, 9], Nigeria
[14, 15], Kenya [16]. The reported reasons implicate
Table 2 Medication and related characteristics of adult patients
on ART in public health institutions in Harar and Dire Dawa
towns, Eastern Ethiopia, 2012
Characteristics Frequency(N = 620) Percent (%)
Duration after knowing sero status in weeks
3–12 weeks 138 22.30
13–24 weeks 62 10.00
>24 weeks 420 67.70
Duration after ART initiation in weeks
1–12 weeks 189 30.50
13–24 weeks 62 10.00










Drugs other than ARV
Yes 462 74.50
No 158 25.50
Number of pills taken in a day
2 tablets 261 42.10
3 tablets 293 47.30
4 tablets 53 8.50
>=5 tablets 13 2.10
History of opportunistic infections(OIs)
Yes 222 35.80
No 398 64.20
Doses of ART status in the last 7 days
Missed 93 15.00
Not missed 527 85.00
Number of doses missed in last 7 days
1–2 doses 64 69.00
3–4 doses 13 14.00









Being away from home
Being busy




Fig. 1 Reasons for skipping ARV drugs among adult patients on ART
in public health institutions in Harar and Dire Dawa towns, Eastern
Ethiopia, 2012
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Table 3 Factors associate with ART adherence among adult patients on ART in public health institutions in Harar and Dire Dawa
towns, Eastern Ethiopia, 2012
Adherence status
Characteristics Adhered No (%) Not Adhered No (%) COR(95 % CI) AOR(95 % CI)
Age in years
18–24 32 (78.8) 9 (22.0) 0.97 (0.42–2.25) 0.84 (0.31–2.25)
25–34 226 (86.3) 36 (13.7) 1.71 (1.00–2.29) 1.27 (0.68–2.37)
35–44 159 (89.9) 18 (10.2) 2.41(1.28–4.54) 2.40 (1.15–5.01)*
> = 45 110 (78.6) 30 (21.4) 1 1
Average income/month
<500.00ETB 123 (94.6) 7 (5.4) 1 1
501–999.00 ETB 61 (92.4) 5 (7.6) 4.09 (1.828–9.187) 6.73 (2.71–16.75)*
>1000.00 ETB 60 (80.0) 15 (20.0) 2.85 (1.100–7.359) 1.62 (0.57–4.58)
Not determined 283 (81.1) 66 (18.9) 0.93 (0.99–1.745) 1.21 (0.59–2.49)
Waiting time
≤30 min 364 (87.5) 52 (12.5) 1.70 (1.12–2.76) 1.36 (0.79–2.34)
>30 min 163 (79.9) 41 (20.1) 1
Depressiom
Yes 257 (81.3) 59 (18.7) 0.55 (0.35–0.87) 0.36 (0.213–0.614)*
No 270 (88.8) 34 (11.2) 1 1
Pill burden
2 tablets 221 (84.7) 40 (15.3) 3.45 (1.08–11.09) 12.98 (2.781–60.59)*
3 tablets 257 (87.7) 36 (12.3) 4.46 (1.38–14.38) 12.90 (2.87–57.94)*
4 tablets 41 (77.4) 12 (22.6) 2.14 (0.59–7.75) 5.87 (1.21–28.54)*
5 tablets and more 8 (61.5) 5 (38.5) 1 1
Substance use
Used 158 (77.8) 45 (22.2) 0.46 (0.29–0.71) 0.612 (0.37–1.03)
Not-used 369 (88.5) 48 (11.5) 1
Opportunistic infections(OIs)
Not encountered 198 (89.2) 24 (10.8) 1.73 (1.05–2.24) 2.81 (1.47–5.36)*
Encountered 324 (82.7) 69 (17.3) 1 1
Disclosure status
No 402 (83.4) 80 (16.6) 0.52 (0.28–0.97) 0.45(0.21–0.97)*
Yes 125 (90.6) 13 (9.4) 1 1
Family support
Good 232 (89.2) 28 (108) 1.83 (1.14–2.94) 2.61(1.47–4.72)*
Poor 295 (89.1) 65 (18.1) 1 1
Adherence counseling
Yes 509 (85.8) 84 (14.2) 3.03 (1.32–6.69) 2.45(0.37–1.03)
No 18 (66.7) 9 (33.3) 1
Well-skilled counselor
Yes 497 (86.1) 80 (13.9) 3.27 (1.47–7.27) 1.22(0.311–4.79)
No 30 (69.8) 13 (30.2) 1
Satisfaction to counselor
Satisfied 493 (89.2) 81 (14.1) 2.15 (1.07–4.32) 1.24(0.38–4.08)
Not satisfied 34 (73.9) 12 (26.1) 1
*Statistically significant association (P <0.05)
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a strong message for future intervention that can be
tailored to each of them. For example, for the reason
mentioned forgetting, it is possible to craft an innova-
tive way like reminding them through message using
mobile technology. At the same time, for patients
who claimed being away from home as a reason, it is
possible to encourage them plan a kind of regular re-
minder for themselves every time the patient going
away from their residential home.
The level of adherence was significantly influenced by
age that patients in age group of 35–44 years old were
more likely to be adherent than the younger and older.
This is in agreement with a study conducted in Kenya
that had found adherence to ART increased with in-
creased age and decrease as the age goes beyond 60 years
[16]. The possible explanation of this might be the youn-
ger might fear sigma and discrimination compared with
middle aged adults. On the other hand, when they are
getting older, the cognitive challenges can exist so that it
decreases the adherence to the treatment.
Patients who had an average income of 501–999.00
ETB were more likely adhered than those earned less
average monthly income (<500.00 ETB). However, a
study in Kenya found that employed patients who had
higher monthly income were less adhered to treatments
[16]. The explanation of this may indicates that lower
level income can expose them to various psychological
issues which can hamper the adherence. It is also appar-
ent that patients who have higher level income are usu-
ally those employed and engaged in business works
which in one way can subject them busy and away from
home periodically.
Depressed patients were about 0.36 times less likely
adherent than those non-depressed. Other comparable
findings were also documented from within and outside
of the country [8–10, 17]. This might be explained as
that those depressed patients usually experience hope-
lessness and demoralization which can expose them
skipping or forgetting their regular treatment. This find-
ing has a strong implication that there is a need to de-
sign to screen patients on a regular bases and then
provide them appropriate counseling.
Those who did not disclose about own sero-status was
found to be associated with adherence similar to other
studies conducted in different parts of Ethiopia [8, 10].
When there is no self- disclosure, the persons may fear
to take their treatments when other people present. In
such case there is a need to develop skill to maintain ad-
herence in the non-disclosure state or design a way to
encourage for disclosure.
Those patients taking less pill burden were more likely
adherent. The finding is comparable with previous re-
ports that pill burden likely decreases the ART adher-
ence [18, 19]. This might be associated with when a
number of pill increases, it may subjects them to experi-
ence more adverse effects from the medications which
potentially lead them to skip their treatment.
It was revealed that patients who did not encounter
opportunistic infections had more adherences to their
treatment which is consistent with the finding of other
study in, United State of America [21] and England [22].
This might show the multiple occurrences of the infec-
tions potentially increase pill burden which can be asso-
ciated with increased level of adverse reaction so that
influence the treatment adherence.
Patients who got family support were more likely ad-
hered than the counterparts consistent with studies in
Jimma [8, 9]. Most of the time, the support start from
accepting HIV result that would result in disclosing their
status possibly received support from their family and
friends which have immediate and long term positive
influences on their adherence [20].
The finding of this study should need to be interpreted
with some limitations. The measurement of adherence
was only relied on patients’ report of missed doses. It
may be subjected to social desirability and recall bias
which leads to overestimation of adherence level.
Conclusions
The ART adherence level in this study was 85 % which is
sub optimal (<95 % adherence level). It was revealed that
the patient age, middle level of monthly income,
depression, pill burden, opportunistic infections, disclosure
status and family support were the predictors of ART ad-
herence. Collaborative efforts of the Regional Health Office,
Regional HIV/AIDS prevention coordinating office, adher-
ence counselors and adherence supports were recom-
mended to draw effective and efficient interventions
targeting these factors.
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